135 related articles for article (PubMed ID: 10517346)
1. Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines.
Tong D; Czerwenka K; Sedlak J; Schneeberger C; Schiebel I; Concin N; Leodolter S; Zeillinger R
Breast Cancer Res Treat; 1999 Jul; 56(1):91-7. PubMed ID: 10517346
[TBL] [Abstract][Full Text] [Related]
2. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R
Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938
[TBL] [Abstract][Full Text] [Related]
3. Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimens.
Knowlden JM; Gee JM; Bryant S; McClelland RA; Manning DL; Mansel R; Ellis IO; Blamey RW; Robertson JF; Nicholson RI
Clin Cancer Res; 1997 Nov; 3(11):2165-72. PubMed ID: 9815611
[TBL] [Abstract][Full Text] [Related]
4. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
[TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
6. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
Lu D; Kiriyama Y; Lee KY; Giguère V
Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
[TBL] [Abstract][Full Text] [Related]
8. Effect of a carotene concentrate on the growth of human breast cancer cells and pS2 gene expression.
Nesaretnam K; Jin Lim E; Reimann K; Lai LC
Toxicology; 2000 Oct; 151(1-3):117-26. PubMed ID: 11074306
[TBL] [Abstract][Full Text] [Related]
9. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.
Bieche I; Parfait B; Le Doussal V; Olivi M; Rio MC; Lidereau R; Vidaud M
Cancer Res; 2001 Feb; 61(4):1652-8. PubMed ID: 11245479
[TBL] [Abstract][Full Text] [Related]
10. Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression.
Martens JW; Sieuwerts AM; Bolt-deVries J; Bosma PT; Swiggers SJ; Klijn JG; Foekens JA
Thromb Haemost; 2003 Feb; 89(2):393-404. PubMed ID: 12574821
[TBL] [Abstract][Full Text] [Related]
11. Expression of the human MTA1 gene in breast cell lines and in breast cancer tissues.
Tong D; Heinze G; Schremmer M; Schuster E; Czerwenka K; Leodolter S; Zeillinger R
Oncol Res; 2007; 16(10):465-70. PubMed ID: 18196870
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7.
Ren L; Marquardt MA; Lech JJ
Chem Biol Interact; 1997 Apr; 104(1):55-64. PubMed ID: 9158695
[TBL] [Abstract][Full Text] [Related]
13. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.
Witzel ID; Milde-Langosch K; Wirtz RM; Roth C; Ihnen M; Mahner S; Zu Eulenburg C; Jänicke F; Müller V
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1709-18. PubMed ID: 20204407
[TBL] [Abstract][Full Text] [Related]
14. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases--a comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases.
Fisher JL; Field CL; Zhou H; Harris TL; Henderson MA; Choong PF
Breast Cancer Res Treat; 2000 May; 61(1):1-12. PubMed ID: 10930085
[TBL] [Abstract][Full Text] [Related]
15. ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1.
Sánchez-Tilló E; de Barrios O; Siles L; Amendola PG; Darling DS; Cuatrecasas M; Castells A; Postigo A
Clin Cancer Res; 2013 Mar; 19(5):1071-82. PubMed ID: 23340304
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation.
Whelan RD; Hill BT
Breast Cancer Res Treat; 1993; 26(1):23-39. PubMed ID: 8400321
[TBL] [Abstract][Full Text] [Related]
17. [Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine].
Fan J; Lu JS; Yin WJ; Lei W; Wu FY; Wu J; Hou YF; Li DQ; Di GH; Shen ZZ; Shao ZM
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):886-9. PubMed ID: 17533736
[TBL] [Abstract][Full Text] [Related]
18. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.
Whitley BR; Palmieri D; Twerdi CD; Church FC
Exp Cell Res; 2004 Jun; 296(2):151-62. PubMed ID: 15149846
[TBL] [Abstract][Full Text] [Related]
19. Agonist activity of antiestrogen-receptor complexes to regulate urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) endogenous gene expression in breast cancer cells.
Levenson AS; Svoboda KM; Kwaan HC; Jordan VC
Cancer Lett; 1998 Mar; 125(1-2):215-20. PubMed ID: 9566718
[TBL] [Abstract][Full Text] [Related]
20. Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels.
Hall RE; Lee CS; Alexander IE; Shine J; Clarke CL; Sutherland RL
Int J Cancer; 1990 Dec; 46(6):1081-7. PubMed ID: 2249895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
